Inclusion Criteria:

          1. Age 18~80 years old, male or female;

          2. Life expectancy≥6 months;

          3. ECOG score: 0-2;

          4. Advanced Solid Tumor were diagnosed by histology and cytology;

          5. Enough venous channel,no other contraindications to the separation and collection of
             white blood cells;

          6. Immunohistochemistry and RT-PCR technology will be used to determine the positive EGFR
             family (including EGFR, HER2, HER4) and EGFRVIII、IGF1R protein. At least one protein
             expressed in immunohistochemical tumor tissue should be no less than grade 2 or 2+
             scores. The levels of protein are defined as follows: (according to cell staining) :
             grade 0: without staining; grade 1: 1-25%; grade 2: 26-50% and grade 3: 51-100%;
             (According to the intensity): negative; 1+; 2+ and 3+;

          7. Laboratory examination: white blood cell≥3 x 10*9/L, blood platelet count≥60 x10*9/L,
             hemoglobin≥85g/L; lymphocyte ≥0.7×109/L, total bilirubin less than 2.5 times of the
             normal level; ALT and AST less than 2.5 times of the normal level; serum creatinine
             less than 1.5 times of the normal level；

          8. Signed informed consent；

          9. Women of child-bearing age must have evidence of negative pregnancy test and be
             willing to practice birth control after 4 months following the cells transfusion.

         10. Disease progression and the current treatment is invalid.

         11. The treatment effect is not ideal after receiving 2 line therapy at least and willing
             to join in clinical trials

        Exclusion Criteria:

          1. Expected Overall survival < 6 months;

          2. Patients with uncontrolled hypertension,unstable coronary disease (uncontrolled
             arrhythmias, unstable angina, decompensated congestive heart failure (> Class II,
             NYHA), or myocardial infarction within 6 months.

          3. Abnormal lung function: FEV (forced expiratory volume) < 30% prediction, DLCO
             (diffusing capacity of the lung for carbon monoxide) < 30% prediction, blood oxygen
             saturation < 90%;

          4. Other serious diseases: nervous, mental disorders, immune regulatory diseases,
             metabolic diseases, infectious diseases, etc;

          5. Unable or unwilling to provide informed consent, or fail to comply with the test
             requirements.

          6. Uncontrolled active infection.

          7. Serious chronic disease of critical organs such as kidney and liver. Kidney function
             more than CKD stage I,and liver function less than the Child - Pugh class B;

          8. Long-term use or being used of immunosuppressive drugs with autoimmune diseases

          9. Glucocorticoid is needed in a long term.

         10. Currently (within 30 days) enrolled in another clinical trial.

         11. Pregnancy or breastfeeding women.